Fingolimod Hydrochloride CAS 162359-56-0 Maʻemaʻe ≥99.0% (HPLC) API Hale Hana Maʻemaʻe Kiʻekiʻe

ʻO ka wehewehe pōkole:

Inoa Kemika: Fingolimod Hydrochloride

CAS: 162359-56-0

Ke 'ano: Pada ke'oke'o i ka pauka ke'oke'o

Maʻemaʻe: ≥99.0% (HPLC)

ʻO ka lāʻau lapaʻau FDA i ʻae ʻia no ka mālama ʻana i ka Multiple Sclerosis.

API no ke kūlana kiʻekiʻe, hana kālepa

Inquiry: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Mea Hana me ka Maʻemaʻe kiʻekiʻe a me ka maikaʻi paʻa
Inoa Kemika: Fingolimod Hydrochloride
CAS: 162359-56-0
ʻO Fingolimod Hydrochloride kahi lāʻau lapaʻau FDA i ʻae ʻia no ka mālama ʻana i ka Multiple Sclerosis.
API no ke kūlana kiʻekiʻe, hana kālepa

Na Waiwai Kemika:

Inoa Kimia Fingolimod Hydrochloride
Nā huaʻōlelo like Fingolimod HCl;FTY 720
Helu CAS 162359-56-0
Helu CAT RF-API39
Kūlana Kūʻai Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā haneli kilogram
ʻĀpana Molekala C19H34ClNO2
Kaumaha Molecular 343.93
Lae hehee 102.0~107.0°C
Brand Kemika Ruifu

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Keʻokeʻo a hiki i ka pauda keʻokeʻo
ʻIkepili HPLC
Lae hehee 102.0~106.0 ℃
Ka hikiwawe Paʻa loa i ka wai
Maʻemaʻe / Kaʻina Hanana ≥99.0% (HPLC)
Māmā (KF) ≤0.50%
Koena ma ka Ignition ≤0.20%
Nā Metala Kaumaha ≤20ppm
Nā mea hoʻoheheʻe koena
Dichloromethane ≤0.05%
Ethyl Acetate ≤0.50%
Ethanol ≤0.50%
Methanol ≤0.30%
Toluene ≤0.089%
THF ≤0.50%
DMF ≤0.088%
Na mea pili
Hoʻokahi haumia ≤0.50%
Huina paumaele ≤1.0%
Kūlana hoʻāʻo Kūlana ʻoihana
Hoʻohana Mea Hana Lapaʻau Hoʻoikaika (API)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.

Pono:

1

FAQ:

Noi:

ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana nui a me ka mea hoʻolako o Fingolimod Hydrochloride (CAS: 162359-56-0) me ke kūlana kiʻekiʻe.
ʻO Fingolimod Hydrochloride ka lāʻau lapaʻau waha mua no ka mālama ʻana i ka maʻi sclerosis.Ua hoʻomohala maikaʻi ʻia e ka hui lāʻau lapaʻau Novartis, a ua ʻae ʻia no ke kūʻai ʻana e ka US Food and Drug Administration (FDA).ʻO ka maʻi sclerosis he maʻi neurological hoʻonāwaliwali e hiki ke hoʻoneʻe i ka mea maʻi i ke ʻano o ke kaulike, ʻike ʻia nā ʻiʻo spasms a me nā pilikia ʻē aʻe.ʻO Fingolimod Hydrochloride kahi modulator receptor sphingosine-l-phosphate (S1PR).Ma hope o ka phosphorylation, ua hoʻopaʻa ʻia i ka s1P receptor aia ma ka ʻili o ka lymphocyte, ka mea e hoʻololi i ka neʻe ʻana o ka lymphocyte, a hoʻolaha i nā cell i loko o ka ʻiʻo lymphatic, a pale aku i nā lymphocytes mai ka haʻalele ʻana i ka ʻiʻo lymphoid a komo i loko o ka graft.Ma laila, e pale aku ai i kēia mau cell mai ka hoʻokomo ʻana i ke kikowaena o ke kikowaena (CNS), kahi e hoʻokō ai i ka hopena o ka immunosuppression.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou